36.7 F
New York
Thursday, April 22, 2021

Moderna Inc.’s [NASDAQ: MRNA] Board Member Dr. Nabel Resigns

Must read

Palantir [NYSE: PLTR] Recognized as a Crown Commercial Service supplier

Palantir Technologies Inc. has gained recognition as a supplier on the Crown Commercial Service (CCS) Back Office Software (BOS) RM6194 Framework. This award...

Trevena [NASDAQ: TRVN] Soar on Selection of TRV027in Global COVID-19 Trial

Shares of Trevena, Inc. skyrocketed more than 5 percent during the pre-market trading session of Wednesday. The strong performance of the firm indicated...

InfuSystem Announces Acquisition of OB Healthcare Corporation

InfuSystem Holdings Inc. disclosed Wednesday that it has bought OB Healthcare Corporation. As per the acquisition agreement, the firm has purchased the operating...

IAA [NYSE: IAA] Announces Expansion of Delivery Services in the UK

IAA, Inc. disclosed that its UK-based business unit has decided to expand its vehicle delivery services for its buyers. This expansion decision has...

Moderna Inc.[NASDAQ: MRNA], a clinical-stage biotechnology company disclosed that Dr. Nabel Elizabeth from the board of directors resigned. She is the president of Brigham and Women’s Hospital.

Brigham and Women’s Hospital is one of the 89 clinical trial sites in the phase 3 trial of mRNA-1273, a vaccine candidate against COVID-19 of Moderna. Noubar Afeyan, Ph.D., Co-Founder and Chairman of¬†Moderna, and CEO of Flagship Pioneering thanked her for her services in Moderna Board.

Shares of Moderna Inc. dropped 2.36% at $77.63 during the trading of Thursday. It has day low and day high range of $76.80-$79.25, respectively. It had trading volume of 13 million as compared to the avearge volume of 27.17 million.

In the past 52-weeks of trading this company’s stocks have fluctuated between the low of $11.54 and a high of $95.21. It has moved up 572.70% from 52-weeks low and moved down -18.46% from its 52-weeks high.

If we look at its profitability, its return on assets (ROA) is -29.20%, return on equity (ROE) is -37.40%, and return on investment (ROI) is -44.90%. It has recorded the sales of 52.60 million.

Her experience as a clinician and global health leader played a very important role in the progress of Moderna Inc. She has been served in Moderna’s board of directors for five years.

Moderna has accepted her resignation to avoid any conflict of interest amid the Phase 3 trial of the coronavirus vaccine candidate. Moderna Inc has started its late-stage human trials on Monday with the collaboration with the National Institute of Allergy and Infectious Diseases.

More articles

Latest article

ICON [NASDAQ: ICLR] Secures Multiple Categories in 2021 CRO Leadership Awards

ICON Public Limited Company has disclosed that it has won multiple categories in the annual CRO Leadership Awards. This is another greatest achievement...

Equinox Announces Sale of Pilar Gold Mine

Equinox Gold Corp. revealed Monday that it has decided to sell its Pilar Gold Mine in Brazil to Pilar Gold Inc. The firm...

OpGen [NASDAQ: OPGN] Announces Strategic Collaboration New York State Department of Health

OpGen, Inc. revealed that it has entered into a strategic collaboration deal with the New York State Department of Health. The focus of...

Why Mer Telemanagement [NASDAQ: MTSL] Skyrocketed on Friday?

Shares of Mer Telemanagement Solutions Ltd skyrocketed during the trading session of Friday. The strong performance of the firm has indicated the positive...

Largo Resources Gets Approval for Listing on Nasdaq Stock Exchange

Largo Resources disclosed that it has finally obtained authorization from Nasdaq Stock Market LLC. As per the approval, the firm will now eligible to...

Aurora Mobile [NASDAQ: JG] Inks Agreement with Wanda Film

Aurora Mobile Limited disclosed Thursday that it has inked an agreement with Wanda Film Holding Co Ltd. Since its inception, Aurora Mobile has...

Brady [NYSE: BRC] Commence Tender Offer to Buy Nordic ID Oyj

Brady Corporation has inked an agreement with Nordic ID for its acquisition. The firm has commenced the tender offering to buy all the...

Cinedigm [NASDAQ: CIDM] Achieve Record Subscription and Ad-Supported User Growth Milestones

Shares of Cinedigm Corp. skyrocketed 19.30% after the firm reported the update about the subscription. The firm has achieved the best ever achievement...